Saturday, July 12, 2014

5 Best Life Sciences Stocks To Watch For 2015

5 Best Life Sciences Stocks To Watch For 2015: Keryx Biopharmaceuticals Inc.(KERX)

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease. The company?s products under development include KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, as well as affects other pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival. Its KRX-0401 is in Phase III clinical development stage for the treatment of refractory advanced colorectal cancer and multiple myeloma, as well as in Phase I and Phase II clinical development stages for the treatment of other tumor types. The company is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that is in Phase III clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease o n dialysis. Keryx Biopharmaceuticals, Inc. has commercial license agreements with Zentaris AG for the development of KRX-0401; Panion & BF Biotech, Inc. for the development and marketing of Zerenex; and Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. The company was founded in 1997 and is based in New York, New York.

Advisors' Opinion:
  • [By gurujx]

    Keryx Biopharmaceuticals Inc. (KERX): CFO James F. Oliviero III Sold 109,500 Shares

    CFOJames F. Oliviero IIIsold 109,500 shares of KERX stock on 12/30/2013 at the average price of $12.64. James F. Oliviero III owns at least 476,429 shares after this. The price of the stock has decreased by 3.32% since.

  • source from Top Penny Stocks For 2015:http://www.topstocksforum.com/5-best-life-sciences-stocks-to-watch-for-2015-2.html

No comments:

Post a Comment